Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Events / Regulatory / Philips Elevate Plus FDA Clearance
Regulatory regulatory clearance

Philips Elevate Plus FDA Clearance

Analysis based on 8 articles · First reported Jun 02, 2026 · Last updated Jun 02, 2026

Sentiment
60
Attention
4
Articles
8
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The regulatory clearance of Elevate Plus for Philips' ultrasound systems is expected to positively impact Philips' stock price due to enhanced product offerings and market competitiveness. This development could also influence the broader health technology sector by setting new standards for AI integration in medical imaging.

Health Technology Medical Devices
Event Summary

Philips announced that its Elevate Plus ultrasound system, featuring advanced AI and automation capabilities, received 510(k) clearance from the United States — Food and Drug Administration in the United States. This clearance allows Philips to commercialize Elevate Plus for its EPIQ Elite and Affiniti ultrasound systems, aiming to standardize routine exams, reduce repeat scanning, and deliver more consistent, high-quality ultrasound images faster. Clinicians from Boston Medical Center and Hospital das Clínicas, School of Medicine, University of São Paulo, have provided positive feedback, noting significant reductions in scanning time and improved workflow efficiency. The system also includes Koios AI decision support for classifying breast lesions and thyroid nodules.

Key Actions
100 United States — Food and Drug Administration granted 510(k) clearance Philips
90 Philips announced regulatory clearance
Entities Involved
stock
Philips
Philips received FDA 510(k) clearance for its Elevate Plus ultrasound system, enhancing its position in AI-powered health technology and potentially increasing sales and market share.
Importance 100 Sentiment 70
govactor
United States — Food and Drug Administration
The United States — Food and Drug Administration granted 510(k) clearance to Philips' Elevate Plus, enabling the product's commercialization in the USA.
Importance 80 Sentiment 0
oth
Boston Medical Center
Boston Medical Center's Ultrasound Manager, Gretchen Sammy, provided positive feedback on the Elevate Plus system, highlighting its potential to improve workflow efficiency and reduce scanning time.
Importance 40 Sentiment 20
oth
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Maria Cristina Chammas, Director of Ultrasound Division at Hospital das Clínicas, School of Medicine, University of São Paulo, praised Elevate Plus for its potential to improve workflow efficiency and reduce sonographer fatigue.
Importance 40 Sentiment 20
cnt
United States
The United States is the market where Philips received regulatory clearance for its Elevate Plus system, allowing its use in the country.
Importance 30 Sentiment 0
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.